(MENAFN- EIN Presswire) Companies like Boston Scientific, Penumbra, and Stryker are advancing thrombectomy devices, enhancing diagnosis and improving patient outcomes. LAS VEGAS , NV, UNITED ...

Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Countries committed to rolling out endovascular thrombectomy services are meeting with varying degrees of success.

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at $4.9 billion.

Argon Medical Devices announced the first patient enrollment in the CLEAN-PE study, which is estimated to enroll > 100 patien ...

Contego’s portfolio includes the Neuroguard carotid stent system and Excipio thrombectomy devices. The Neuroguard system is ...

Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of ...

Penumbra (PEN) stock rises as Stryker (SYK) agrees to acquire its rival in the thrombectomy market, Inari Medical (NARI) for $4.9B in cash. Read more here.